Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 12/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23966531 | 0.92 | S1PR2 (0.87) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23966542 | 0.91 | S1PR2 (0.82) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908982 | 0.91 | S1PR2 (1.00) | S1PR2TP53 | |
| SCHEMBL23914603 | 0.89 | S1PR2 (0.81) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908951 | 0.85 | S1PR2 (1.00) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23914693 | 0.85 | S1PR2 (0.82) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908889 | 0.82 | S1PR2 (0.93) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23915204 | 0.81 | S1PR2 (0.77) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23914706 | 0.81 | S1PR2 (0.82) | S1PR2CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908925 | 0.80 | S1PR2 (1.00) | S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649119-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | GALAPAGOS NV (BE) | 2021-11-03 | — | — | EP | disclosed |